Recent Finacing
Recent Raise
Epigenic Therapeutics develops AI‑driven epigenetic gene‑modulation therapies using EPIREG to design non‑cleaving CRISPR‑based effectors and EpiTax LNP delivery for liver, ocular, metabolic, cardiovascular, and rare disease targets.
